The cash backs phase 3 trials of the injectable and oral GLP-1/GIP drug, with Vanquish results due in 2027 and Sunrise likely in 2028.
Recap by typeshit. Full story at Yahoo Finance.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
A general explainer on why the body holds onto its large fat reserves even though they carry tens of thousands of calories.
She points out one trial enrolled people with diabetes and the other excluded them, so the results aren't a head to head match.
Loading…